Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers01:17

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Chemical Signaling in the Endocrine System01:08

Chemical Signaling in the Endocrine System

A signaling cascade is a series of events that facilitates the transmission of information within or between cells, culminating in a targeted response in the recipient cell. As chemical messengers, hormones are pivotal in initiating and modulating these intricate signaling cascades based on their solubility.
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials.

Cancers·2026
Same author

Pediatric solitary pulmonary tuberculoma mimicking peripheral pulmonary hamartoma with extensive pleural adhesions: a case report.

Frontiers in medicine·2025
Same author

Analysis of risk factors for postoperative complications in hypospadias and construction and validation of a nomogram predictive model.

PloS one·2025
Same author

Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLER.

JNCI cancer spectrum·2025
Same author

Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort Study.

JCO oncology practice·2025
Same author

Four-point vaginal reconstruction versus conventional suturing techniques for the treatment of congenital vaginal atresia: a prospective randomized controlled trial.

Frontiers in pediatrics·2025
Same journal

Beyond Respiratory Depression: Acute and delayed pulmonary responses following aerosolized fentanyl exposure.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

Molecular Dosimetry of DNA Adducts in Mice Exposed to Ethylene Oxide.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

Exposure timing is a determinant of fine particulate matter (PM2.5) pulmonary, vascular and metabolic toxicity in male mice.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

A fond farewell to Jeffrey Peters, editor-in-chief of ToxSci.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

Aryl hydrocarbon Receptor Nuclear Translocator 2: A Forgotten Per-ARNT-Sim Transcription Factor.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

ToxMet: a web tool for toxicogenomic data analysis using genome-scale metabolic modeling.

Toxicological sciences : an official journal of the Society of Toxicology·2026
See all related articles

Related Experiment Video

Updated: May 9, 2026

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory
14:13

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory

Published on: January 1, 2018

EADB: an estrogenic activity database for assessing potential endocrine activity.

Jie Shen1, Lei Xu, Hong Fang

  • 1* Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas 72079;

Toxicological Sciences : an Official Journal of the Society of Toxicology
|July 31, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces the Estrogenic Activity Database (EADB), a comprehensive resource for estrogenic activity data. EADB aids scientists in assessing the risks and benefits of endocrine-active chemicals.

Keywords:
database.endocrine disruptorestrogen receptorestrogenic activity

More Related Videos

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
08:00

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Related Experiment Videos

Last Updated: May 9, 2026

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory
14:13

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory

Published on: January 1, 2018

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
08:00

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Area of Science:

  • Environmental Science
  • Toxicology
  • Biochemistry

Background:

  • Endocrine-active chemicals pose risks to humans and wildlife by interfering with endocrine systems.
  • Estrogen receptors (ERs) are key targets for endocrine disruptors and therapeutic interventions.
  • Existing estrogenic activity data are fragmented, hindering risk-benefit assessments.

Purpose of the Study:

  • To consolidate and provide public access to estrogenic activity data.
  • To facilitate the evaluation of chemical safety and therapeutic potential.
  • To support regulatory and industry scientific endeavors.

Main Methods:

  • Development of the Estrogenic Activity Database (EADB).
  • Compilation of 18,114 data points for 8212 chemicals from 1284 assays across 11 species.
  • Creation of tools for data access and analysis, including a predictive classification model.

Main Results:

  • EADB offers a unified, accessible repository of estrogenic activity data.
  • The database covers diverse chemicals and assay types, providing a broad range of activity information.
  • A classification model for predicting ER binding was successfully developed using EADB.

Conclusions:

  • EADB is a valuable public resource for understanding chemical estrogenicity.
  • The database empowers scientists to better assess chemical risks and therapeutic applications.
  • EADB supports advancements in endocrine disruptor research and chemical safety evaluations.